Baiotech: Golimumab Injection Receives Positive Opinion from EMA

Baiotai announcement, recently received notification from the European Medicines Agency, Gotenfia has received a positive opinion from the EMA Human Medicines Committee. CHMP recommends that the European Commission approve the marketing of Gotenfia for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.